生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Cyclin-dependent kinases (CDKs) are a family of protein kinases which along with their regulatory subunit cyclins play a key role in the growth, development, proliferation and death of eukaryotic cells and are responsible for insuring integrity in the coordination of events through the cell cycle[3]. BMS-265246 has been identified as a potent, selective inhibitor of CDK1 (IC50 = 0.006 μM) and CDK2 (IC50 = 0.009 μM) in vitro. In an ovarian cancer cell line (A2780) inhibitor BMS-265246 produced a cytotoxic effect with an IC50 = 0.76 μM[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.90mL 0.58mL 0.29mL |
14.48mL 2.90mL 1.45mL |
28.96mL 5.79mL 2.90mL |
参考文献 |
---|